Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-018545
Filing Date
2015-05-08
Accepted
2015-05-08 17:00:49
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-Q 3-31-2015 form10q.htm 10-Q 570626
2 EXHIBIT 31 ex31.htm EX-31 19097
3 EXHIBIT 32 ex32.htm EX-32 5398
  Complete submission text file 0001140361-15-018545.txt   5083947

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ast-20150331.xml EX-101.INS 515195
5 XBRL TAXONOMY EXTENSION SCHEMA ast-20150331.xsd EX-101.SCH 43217
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20150331_cal.xml EX-101.CAL 56454
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20150331_def.xml EX-101.DEF 186526
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20150331_lab.xml EX-101.LAB 579624
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20150331_pre.xml EX-101.PRE 328754
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36646 | Film No.: 15847691
SIC: 2836 Biological Products, (No Diagnostic Substances)